Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial

BACKGROUND: Raising T-cell response against antigens either expressed on normal and malignant plasma cells (e.g. HM1.24) or aberrantly on myeloma cells only (e.g. cancer testis antigens, CTA) by vaccination is a potential treatment approach for multiple myeloma. RESULTS: Expression by GEP is found f...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Michael, Hückelhoven, Angela G., Hundemer, Michael, Schmitt, Anita, Lipp, Susanne, Emde, Martina, Salwender, Hans, Hänel, Mathias, Weisel, Katja, Bertsch, Uta, Dürig, Jan, Ho, Anthony D., Blau, Igor Wolfgang, Goldschmidt, Hartmut, Seckinger, Anja, Hose, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689578/
https://www.ncbi.nlm.nih.gov/pubmed/29156688
http://dx.doi.org/10.18632/oncotarget.11215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689578/
https://www.ncbi.nlm.nih.gov/pubmed/29156688
http://dx.doi.org/10.18632/oncotarget.11215

Ejemplares similares